Scholtz & Company’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45K | Hold |
20,000
| – | – | 0.02% | 52 |
|
|
2025
Q1 | $27.4K | Hold |
20,000
| – | – | 0.01% | 51 |
|
|
2024
Q4 | $31.6K | Hold |
20,000
| – | – | 0.02% | 48 |
|
|
2024
Q3 | $24.8K | Hold |
20,000
| – | – | 0.01% | 51 |
|
|
2024
Q2 | $26.8K | Hold |
20,000
| – | – | 0.01% | 50 |
|
|
2024
Q1 | $27.2K | Hold |
20,000
| – | – | 0.01% | 50 |
|
|
2023
Q4 | $52K | Hold |
20,000
| – | – | 0.03% | 66 |
|
|
2023
Q3 | $64K | Buy |
20,000
+5,000
| +33% | +$16K | 0.04% | 40 |
|
|
2023
Q2 | $75K | Buy |
15,000
+5,000
| +50% | +$25K | 0.05% | 38 |
|
|
2023
Q1 | $29K | Buy |
+10,000
| New | +$29K | 0.02% | 34 |
|